platoseedplatoseed
New clinical tests for managing autoimmune treatments.
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Coral Genomics is described as providing new clinical tests to assist in managing autoimmune treatments. The text positions Coral Genomics within a clinical testing context aimed at treatment management for autoimmune conditions.
The product consists of clinical tests designed to aid in managing autoimmune therapies. The tests presumably generate insights to inform treatment decisions, enabling healthcare providers to tailor management of autoimmune conditions, though no specific assay names or technical details are provided in the text.
Who it’s for: Healthcare providers and systems involved in autoimmune disease management, including clinicians and clinics ordering diagnostic tests for autoimmune treatment decisions.
Formerly “WeSeq” · why startups rename →
Our tests help eradicate cancer by telling doctors whether they got…
Cofactor closes the precision medicine gap with predictive diagnostics
